Large balloon dilation post endoscopic sphincterotomy in removal of difficult common bile duct stones: A literature review

Table 1 Patient outcomes after endoscopic sphincterotomy combined with large balloon dilation

Ref.	Study type	No. patients ESLBD	Dilating balloon diamete (mm)	Success at index ERCP (%)	ML (%)
Ersoz et al[9]	R	58	12-20	82.8	6.9
Bang et al[12]	P	22	12-15	72.7	9.1
Espinel et al[55]	P	22	12-20	100	3.2
Lee et al[13]	R	55	15-20	100	5.5
Minami et al[28]	R	88	20	99	1
Maydeo et al[34]	P	60	15	95	5
Heo et al[20]	RCT	100	12-20	83	8
Kim et al[51]	R	9	12-18	55	11
Attasaranya et al[29]	R	103	12-18	95	27
Misra et al[35]	R	50	15-20	100	10
Itoi et al[15]	RA	53	15-20	96	5.6
Park et al[44]	R	6	12-15	33	50
Kim et al[19]	RCT	27	15-18	85	33
Itoi et al[27]	R	18	15-18	94	22
Kim et al[42]	R	70	12-18	97	1.4
Itoi et al[52]	R	11	15-20	100	18.2
Kurita et al[43]	R	24	15-20	96	4.2
Youn et al[32]	R	101	15-20	92	6.9
Kim et al[53]	R	16	12-18	94	6.3
Itoi et al[54]	R	15	15-20	100	6.7
Stefanidis et al[17]	RCT	45	15-20	98	0
Kim et al[16]	RA	72	12-20	88	17.9
Rosa et al[14]	R	30	12-18	84	20
Paspatis et al[48]	RCT	124	15-20	86	3.2
Sakai et al[47]	R	59	12-20	83.1	13.6
Yang et al[23]	R	169	12-18	95.3	38.6
Poincloux et al[45]	R	62	15-20	95	3.2
Harada et al[25]	R	30	15-20	97	10
Yoon et al[41]	R	52	12-20	ND	23
Teoh et al[18]	RCT	73	13-15	89	28.8
Hwang et al[56]	RCT	69	12-20	94	26.1
Rosa et al[14]	RA	68	12-18	82.4	14.7

ESLBD: Endoscopic sphincterotomy combined with large balloon dilation; ERCP: Endoscopic retrograde cholangiopancreatography; ML: Mechanical lithotripsy; R: Retrospective series; P: Prospective series; RCT: Randomized: controlled trial; RA: Retrospective analysis; ND: Not determined.

Table 2 Rates of adverse events after endoscopic sphincterotomy combined with large balloon dilation n (%)

Ref.	No. patients ESLBD	PEP	Bleeding	Perforation	Cholangitis	Miscellaneous	Overall AEs
Ersoz et al[9]	58	2 (3.4)	5 (8.6)	0	2 (3.4)	0	9 (15.5)
Bang et al[12]	22	1 (4.5)	0	0	0	0	1 (4.5)
Espinel et al[55]	22	0	0	0	0	0	0
Lee et al[13]	55	0	0	0	0	0	0
Minami et al[28]	88	1 (1.1)	1 (1.1)	0	1 (1.1)	12 (13.6)	15 (17.0)
Maydeo et al[34]	60	0	5 (8.3)	0	0	0	5 (8.3)
Heo et al[20]	100	4 (4.0)	0	0	0	1 (1.0)	5 (5.0)
Kim et al[51]	9	0	0	0	0	0	0
Attasaranya et al[29]	103	0	2 (1.9)	1 (1.0)	0	3 (2.9)	6 (5.8)
Misra et al[35]	50	4 (8.0)	3 (6.0)	0	0	0	7 (14.0)
Itoi et al[15]	53	1 (1.9)	0	0	1 (1.9)	0	2 (3.8)
Park et al[44]	6	0	1 (16.7)	0	0	0	1 (16.7)
Kim et al[19]	27	0	0	0	0	0	0
Itoi et al[27]	18	0	0	0	0	0	0
Kim et al[42]	70	1 (1.4)	0	0	0	0	1 (1.4)
Itoi et al[52]	11	0	0	0	0	0	0
Kurita et al[43]	24	0	0	0	0	0	0
Youn et al[32]	101	5 (5.0)	2 (2.0)	1 (1.0)	0	2 (2.0)	10 (9.9)
Kim et al[53]	16	0	1 (6.3)	0	0	0	1 (6.3)
Itoi et al[54]	15	0	0	0	0	0	0
Stefanidis et al[17]	45	1 (2.2)	1 (2.2)	0	0	0	4,4
Kim et al[16]	72	5 (6.9)	0	0	1 (1.3)	0	6 (8.3)
Rosa et al[14]	30	1 (3.3)	0	0	0	0	1 (3.3)
Paspatis et al[48]	124	4 (3.2)	6 (4.8)	2 (1.6)	5 (4.0)	0	17 (13.7)
Sakai et al[47]	59	0	1 (1.7)	1 (1.7)	1 (1.7)	1 (1.7)	4 (6.8)
Yang et al[23]	169	2 (1.2)	4 (2.4)	1 (0.6)	1 (0.6)	0	8 (4.7)
Poincloux et al[45]	62	2 (3.2)	5 (8.0)	0	2 (3.2)	0	9 (14.5)
Harada et al[25]	30	0	0	0	0	0	1 (3.3)
Yoon et al[41]	52	0	0	0	0	0	0
Teoh et al[18]	73	2 (2.7)	1 (1.4)	0	1 (1.4)	1 (1.4)	5 (6.8)
Hwang et al[56]	69	3 (4.3)	0	1 (1.4)	0	1 (1.4)	5 (7.2)
Rosa et al[14]	68	9 (13.2)	0	0	1 (1.5)	0	10 (14.7)

ESLBD: Endoscopic sphincterotomy combined with large balloon dilation; PEP: Post-endoscopic retrograde cholangiopancreatography pancreatitis; AE: Adverse event.